{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:21:11Z","timestamp":1770754871104,"version":"3.50.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.nmd.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T01:36:05Z","timestamp":1666143365000},"page":"864-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene"],"prefix":"10.1016","volume":"32","author":[{"given":"Lise","family":"Janssens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"De Puydt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Symoens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan L.","family":"De Bleecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-7849","authenticated-orcid":false,"given":"Sarah","family":"Herdewyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.10.003_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"9134","key":"10.1016\/j.nmd.2022.10.003_bib0002","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(98)03078-5","article-title":"Malignant hyperthermia","volume":"352","author":"Denborough","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2022.10.003_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00001665-200309000-00039","article-title":"Malignant hyperthermia","volume":"14","author":"Halliday","year":"2003","journal-title":"J Craniofac Surg"},{"issue":"10","key":"10.1016\/j.nmd.2022.10.003_bib0006","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2044.1990.tb14566.x","article-title":"Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands","volume":"45","author":"Ellis","year":"1990","journal-title":"Anaesthesia"},{"key":"10.1016\/j.nmd.2022.10.003_bib0007","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/B978-0-444-64074-1.00038-0","article-title":"Malignant hyperthermia","volume":"157","author":"Hopkins","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0008","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbamcr.2010.11.009","article-title":"Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum","volume":"1813","author":"Maclennan","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"5058","key":"10.1016\/j.nmd.2022.10.003_bib0009","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.256.5058.789","article-title":"Malignant hyperthermia","volume":"256","author":"MacLennan","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bja.2020.09.029","article-title":"Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group","volume":"126","author":"R\u00fcffert","year":"2021","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.nmd.2022.10.003_bib0011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","article-title":"Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group","volume":"105","author":"Glahn","year":"2010","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.nmd.2022.10.003_bib0012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1034\/j.1399-6576.2002.460610.x","article-title":"Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations","volume":"46","author":"Rueffert","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"10.1016\/j.nmd.2022.10.003_bib0013","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutations in malignant hyperthermia and central core disease","volume":"15","author":"McCarthy","year":"2000","journal-title":"Hum Mutat"},{"issue":"7","key":"10.1016\/j.nmd.2022.10.003_bib0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tibs.2017.04.005","article-title":"Ca(2+) Release channels join the 'resolution revolution'","volume":"42","author":"Zalk","year":"2017","journal-title":"Trends Biochem Sci"},{"issue":"11 Pt B","key":"10.1016\/j.nmd.2022.10.003_bib0016","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbamcr.2018.07.011","article-title":"Ryanodine receptor dysfunction in human disorders","volume":"1865","author":"Kushnir","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0017","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13395-020-00243-4","article-title":"Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature","volume":"10","author":"Lawal","year":"2020","journal-title":"Skelet Muscle"},{"issue":"3","key":"10.1016\/j.nmd.2022.10.003_bib0018","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"33","key":"10.1016\/j.nmd.2022.10.003_bib0019","doi-asserted-by":"crossref","first-page":"e26999","DOI":"10.1097\/MD.0000000000026999","article-title":"The neuromuscular and multisystem features of RYR1-related malignant hyperthermia and rhabdomyolysis: a study protocol","volume":"100","author":"van den Bersselaar","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","article-title":"Malignant hyperthermia susceptibility and related diseases","volume":"128","author":"Litman","year":"2018","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.nmd.2022.10.003_bib0021","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"issue":"11","key":"10.1016\/j.nmd.2022.10.003_bib0022","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2217\/14622416.9.11.1657","article-title":"Malignant hyperthermia: a pharmacogenetic disorder","volume":"9","author":"Stowell","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10.1016\/j.nmd.2022.10.003_bib0023","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0024","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1038\/s41598-021-82024-7","article-title":"Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance","volume":"11","author":"Hoppe","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.nmd.2022.10.003_bib0025","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/ejhg.2016.63","article-title":"Guidelines for diagnostic next-generation sequencing","volume":"24","author":"Matthijs","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.nmd.2022.10.003_bib0026","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-021-01125-w","article-title":"Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility","volume":"23","author":"Johnston","year":"2021","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0027","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.nmd.2022.10.003_bib0028","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/humu.10098","article-title":"RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes","volume":"20","author":"Robinson","year":"2002","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.nmd.2022.10.003_bib0029","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0000000000004199","article-title":"Referral indications for malignant hyperthermia susceptibility diagnostics in patients without adverse anesthetic events in the era of next-generation sequencing","volume":"136","author":"van den Bersselaar","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2022.10.003_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","article-title":"Anaesthetic deaths in a family","volume":"34","author":"Denborough","year":"1962","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","article-title":"Malignant hyperthermia in the post-genomics era: new perspectives on an old concept","volume":"128","author":"Riazi","year":"2018","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.nmd.2022.10.003_bib0032","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/bja\/aep108","article-title":"Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility","volume":"103","author":"Robinson","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2022.10.003_bib0033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study","volume":"9","author":"Klingler","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.nmd.2022.10.003_bib0034","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.nmd.2022.06.003","article-title":"Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH)","volume":"32","author":"Riazi","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2022.10.003_bib0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1213\/ane.0b013e3181aa5cf6","article-title":"Malignant hyperthermia and muscular dystrophies","volume":"109","author":"Gurnaney","year":"2009","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0036","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mus.880110507","article-title":"Halothane-caffeine contracture testing in neuromuscular diseases","volume":"11","author":"Heiman-Patterson","year":"1988","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0037","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/WCO.0000000000000592","article-title":"Malignant hyperthermia: still an issue for neuromuscular diseases?","volume":"31","author":"De Wel","year":"2018","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2022.10.003_bib0038","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00415-019-09209-z","article-title":"The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations","volume":"266","author":"Knuiman","year":"2019","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2022.10.003_bib0039","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ane.12885","article-title":"Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome","volume":"137","author":"Witting","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"10.1016\/j.nmd.2022.10.003_bib0041","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/ene.12713","article-title":"RYR1-related myopathies: a wide spectrum of phenotypes throughout life","volume":"22","author":"Snoeck","year":"2015","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nmd.2018.10.006","article-title":"Functional impairments, fatigue and quality of life in RYR1-related myopathies: a questionnaire study","volume":"29","author":"van Ruitenbeek","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2022.10.003_bib0043","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1007\/s10072-022-05964-6","article-title":"Adult-onset selective quadriceps femoris weakness in RYR1-related myopathy","volume":"43","author":"de Souza","year":"2022","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2022.10.003_bib0044","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JND-150130","article-title":"Long term oral dantrolene improved muscular symptoms in a malignant hyperthermia susceptible individual","volume":"3","author":"Butala","year":"2016","journal-title":"J Neuromuscul Dis"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:22Z","timestamp":1760775202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622006976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":44,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0960896622006976"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.10.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}